Zebra Technologies (NASDAQ:ZBRA) Releases Quarterly Earnings Results, Beats Estimates By $0.57 EPS

Zebra Technologies (NASDAQ:ZBRA - Get Free Report) announced its quarterly earnings data on Tuesday. The industrial products company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.92 by $0.57, Briefing.com reports. Zebra Technologies had a net margin of 8.20% and a return on equity of 15.56%. The company had revenue of $1.26 billion for the quarter, compared to analysts' expectations of $1.22 billion. During the same period in the previous year, the company posted $0.57 EPS. Zebra Technologies's revenue was up 31.3% compared to the same quarter last year.

Zebra Technologies Stock Performance

NASDAQ:ZBRA traded up $2.67 during mid-day trading on Friday, hitting $384.64. 523,279 shares of the company's stock traded hands, compared to its average volume of 361,617. The firm has a 50 day moving average of $359.28 and a two-hundred day moving average of $330.66. The firm has a market capitalization of $19.84 billion, a price-to-earnings ratio of 52.33 and a beta of 1.66. The company has a current ratio of 1.37, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. Zebra Technologies has a 12 month low of $198.19 and a 12 month high of $394.57.

Wall Street Analysts Forecast Growth

ZBRA has been the subject of several research analyst reports. Vertical Research started coverage on shares of Zebra Technologies in a research report on Tuesday, July 23rd. They set a "buy" rating and a $375.00 price target for the company. Morgan Stanley raised their target price on Zebra Technologies from $290.00 to $305.00 and gave the company an "underweight" rating in a research note on Wednesday. Truist Financial restated a "hold" rating and issued a $383.00 price target (up previously from $379.00) on shares of Zebra Technologies in a research note on Wednesday. Stephens increased their target price on Zebra Technologies from $380.00 to $410.00 and gave the stock an "overweight" rating in a report on Friday, August 2nd. Finally, Barclays lifted their price target on shares of Zebra Technologies from $347.00 to $407.00 and gave the company an "equal weight" rating in a report on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Zebra Technologies has an average rating of "Moderate Buy" and a consensus target price of $385.18.

Insider Buying and Selling

In related news, insider Jeffrey F. Schmitz sold 1,000 shares of the business's stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $341.69, for a total transaction of $341,690.00. Following the transaction, the insider now directly owns 9,694 shares in the company, valued at $3,312,342.86. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.06% of the stock is currently owned by insiders.

Zebra Technologies Company Profile

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.